CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-03). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 2032 · Search date 2026-08-03 · Methodology v0.6

Dried hijiki,
does it really help with Improved weekly mean glucose in adults with type 2 diabetes?

30-Second Summary
D
Evidence Grade D · 31 · Safety warning
Five grams per day of processed hijiki did not improve mean glucose over five weeks
The UK Food Standards Agency advises people not to eat hijiki, and Hong Kong's Centre for Food Safety advises avoiding its consumption and use as an ingredient. The processed study batch measured 0.45 mg/kg inorganic arsenic, or 2.25 micrograms per 5 g, which cannot be generalized to retail hijiki.
What the
research shows
The grade is D with 31 points. In a five-week double-blind randomized trial of 36 overweight adults with type 2 diabetes, 5 g/day hijiki did not improve continuous-monitoring weekly mean glucose versus a 0.5-g dried-nori control. The hijiki-group mean changed from 8.2+/-2.1 to 9.0+/-0.7 mmol/L, with no significant between-group effect.
What the
ads claim
Multiplying the study batch's measured 0.45 mg/kg inorganic arsenic by 5 g dried hijiki gives 2.25 micrograms/day. This was the processed study batch, not a general commercial-hijiki value. The UK Food Standards Agency advises people not to eat hijiki, and Hong Kong's Centre for Food Safety advises avoiding its consumption and use as an ingredient. These are consumption advisories, not a comprehensive statutory ban. The safety warning and null mean-glucose result are separate facts.
*

Useful facts when choosing a product

  • The intervention was 5 g/day dried hijiki for five weeks, not rehydrated weight.
  • The test batch contained 0.45 mg/kg inorganic arsenic, about 2.25 micrograms per 5 g; general commercial values were not substituted for this measurement.
  • Test-product iodine and sodium were not reported. Correcting iodine deficiency and causing thyroid dysfunction through excess are opposite claims.
Gap Measurement · Verdict 2032 · D 31
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Thirty-seven people consented, one failed screening, and 36 were randomized 1:1:1 to hijiki, Fucus vesiculosus, or nori control. Nine withdrew and 27 completed, while the intention-to-treat mixed model included all 36 randomized participants. The hijiki group contained 12 participants and changed from 8.2+/-2.1 to 9.0+/-0.7 mmol/L. No public trial registration number was reported; NL66189.078.18 is an ethics identifier. The study received Health~Holland public-private support, suppliers provided seaweeds, and the authors declared no conflicts of interest.

02

Why this is classified as D (31)

The prespecified paper-level primary mean-glucose endpoint was null in patients, but the missing between-group confidence interval prevents precise exclusion of benefit, giving D with 31 points.

Counterpoint. A larger, preregistered, longer trial with a no-seaweed control and between-group confidence intervals would be needed to narrow remaining uncertainty.

Rejudgment record. Cross-check applied — The null primary weekly-mean-glucose result from the 36-person intention-to-treat mixed model and the missing between-group interval were both applied

Scoring profile behind this grade
EndpointSSurrogate marker - laboratory or imaging measures
ReplicationR1Single confirmatory trial
IndependenceI1Mixed funding sources
Effect sizeE0Null
PrecisionCXNo pooled confidence interval could be confirmed

The scoring table and the verdict agree (D).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Improved weekly mean glucose from 5 g/day dried hijikiDThe primary endpoint was null in the 36-person intention-to-treat mixed model.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Five-week randomized double-blind nori-controlled feasibility trial12Health~Holland LSHI17004 public-private support and supplier-provided seaweeds; authors declared no conflicts of interestChange in weekly mean continuous-monitoring glucoseHijiki group 8.2+/-2.1 to 9.0+/-0.7 mmol/L, within-group P=0.2; no significant effect over time versus control and no between-group CIDirect null evidence for this food and patient population
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-03).

Geurts KAM, Meijer S, Roeters van Lennep JE, et al. The Effect of Sargassum fusiforme and Fucus vesiculosus on Continuous Glucose Levels in Overweight Patients with Type 2 Diabetes Mellitus: A Feasibility Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2024;16:1837. PMID: 38931192. PMCID: PMC11206271.
checked
EFSA CONTAM Panel. Risk assessment of complex organoarsenic species in food. EFSA Journal. 2024;22:e9112.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-03 · Corrections: none

Cite this verdict

Dried hijiki x improved mean glucose in type 2 diabetes Evidence Grade D card
[Chamgap] Dried hijiki x improved mean glucose in type 2 diabetes — Evidence Grade D·31. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/blood-sugar/dried-hijiki-type-2-diabetes-average-glucose/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.